康明永瑞生物科技（苏州）有限公司

康明永瑞生物科技（苏州）有限公司

江苏省南京市常熟市东南街道黄浦江路133号

2022

20至29

不愿意公开

康明永瑞生物科技是一家专业从事多肽以及相关衍生物研发和生产的高新技术型企业，拥有数条完善的多肽生产线, 数台大型的多肽合成、进口分析、制备设备，管理和研发团队具备丰富的创新药物研发和技术服务经验，专注于蛋白质和肽产品的定制合成、工艺开发和药物肽修饰，可为制药企业、生物技术公司、科研单位提供全面服务,可提供从蛋白质和多肽药物的发现到商业化生产的端到端服务，满足任何规模的所有材料要求。

经验丰富的研发人员,发货速度,产品线丰富,接受买家的规格要求,接受小额订单,良好的信誉,优质服务

http://www.combiosz.com/

制造商

北美洲,中/南美洲,西欧,东欧,大洋洲,中东,非洲,亚洲

Glucagon (human)(16941-32-5);GLP-1 (1-37) (human)(87805-34-3);Proinsulin C-Peptide (55-89) (human)(11097-48-6);Exendin-4; Exenatide(141758-74-9);Amylin (human)(122384-88-7);C-Peptide (human); Insulin Precursor (57-87) (human)(33017-11-7);Oxyntomodulin (porcine, bovine)(74870-06-7);GLP-2 (1-33) (human)(223460-79-5);GLP-2 (1-34) (human)(99120-49-7);GLP-1 (1-36) amide (human)(99658-04-5);IGF-I Analog(147819-32-7);Amylin (rat)(124447-81-0);Exendin-4 (9-39)(133514-43-9);GLP-2 (rat)(195262-56-7);Apolipoprotein B Synthetic Peptide();β-Amyloid (1-42) (human)(107761-42-2);β-Amyloid (1-40) (human)(131438-79-4);β-Secretase Substrate I (MCA-DNP pair)();α-Secretase Substrate I（MCA-DNP pair）();β-Amyloid (25-35) (human)(131602-53-4);Galanin (human)(119418-04-1);Humanin (human)(330936-69-1);Galanin (1-13)-Pro-Pro-(Ala-Leu-)2-Ala amide(143896-17-7);Galanin (rat)(114547-31-8);Myelin Oligodendrocyte Glycoprotein (35-55) (rat)(149635-73-4);Myelin Oligodendrocyte Glycoprotein (35-55) (human)(163158-19-8);Influenza Hemagglutinin (HA) Peptide(92000-76-5);LL-37(154947-66-7);C18G(138555-82-5);Fusion Inhibitory Peptide(75539-79-6);Malaria Aspartyl Proteinase FRET Substrate（Dabcyl-Edans pair）(263718-22-5);Leupeptin(103476-89-7);Defensin HNP-3 (human)(136661-76-2);HIV (GP120) Antigenic Peptide(198636-94-1);HIV-1 TAT Protein (47-57)(191936-91-1);CRAMP (mouse)(376364-36-2);β-Defensin-2 (human)(372146-20-8);Apelin (1-13) (human)(217082-58-1);Histatin 5(104339-66-4);HIV (gp41) Fragment(129426-47-7);β-Defensin-1 (human)();Cecropin B(80451-05-4);Somatostatin 14(38916-34-6);Octreotide(79517-01-4);GIP (human)(100040-31-1);Peptide YY (canine, mouse, porcine, rat)(81858-94-8);Peptide YY (human)(118997-30-1);Gastrin 1 (human)(10047-33-3);Caerulein(17650-98-5);Secretin (porcine)(17034-34-3);Gastrin-Releasing Peptide (human)(93755-85-2);VIP receptor antagonist (Human, Bovine, Porcine, Rat)(102805-45-8);DOTA-[Tyr3]-Octreotide(177943-89-4);Secretin (human)(108153-74-8);Insulin B (13 – 23)();Motilin (human, Porcine)(9072-41-7);Pancreatic Polypeptide (rat)(90419-12-8);PHI-27 (rat)(96849-38-6);Uroguanylin (human)(152175-68-3);Angiotensin Converting Enzyme Inhibitor(35115-60-7);Angiotensin II (human)(4474-91-3);Teriparatide acetate(52232-67-4);Glucagon (human)(16941-32-5);Oxytocin(50-56-6);Luteinizinghormone-releasing factor (swine)(35263-73-1);Angiotensin I Converting Enzyme Inhibitor 1(30892-86-5);Somatostatin 14(38916-34-6);Substance P(33507-63-0);ACTH (1-39), human(12279-41-3);Calcitonin (human)(21215-62-3);Antileukinate(138559-60-1);Octreotide(79517-01-4);Calcitonin Gene Related Peptide (human)(90954-53-3);Calcitonin Gene Related Peptide II (human)(98824-26-1);Melanin Concentrating Hormone (human)(128315-56-0);aviptadil(40077-57-4);Luteinizing Hormone-Releasing Hormone Antagonist(292141-31-2);Amylin (human)(122384-88-7);ANP (1-28); Carperitide(89213-87-6);Peptide YY (human)(118997-30-1);Vasoactive intestinal peptide(96886-24-7);Orexin B (mouse)(202801-92-1);Angiotensin III (human)(100900-06-9);Calcitonin (rat)(11118-25-5);Peptide YY (canine, mouse, porcine, rat)(81858-94-8);Orexin A (human)(205640-90-0);Orexin B (human)(205640-91-1);Gastrin 1 (human)(10047-33-3);Calcitonin Gene Related Peptide (rat)(96827-03-1);Caerulein(17650-98-5);Egg Laying Hormone(117680-39-4);Parathyroid Hormone (1-34) (rat)(98614-76-7);Gastrin Releasing Peptide (Porcine)(74815-57-9);GLP-2 (1-34) (human)(99120-49-7);TRH (Human)(24305-27-9);GLP-1 (1-37) (human)(87805-34-3);Neurokinin A (Porcine)(86933-74-6);Angiotensin II (human)(4474-91-3);Angiotensin Converting Enzyme Inhibitor(35115-60-7);Angiotensin I Converting Enzyme Inhibitor 2();Angiotensin I Converting Enzyme Inhibitor 1(30892-86-5);Calcitonin Gene Related Peptide (human)(90954-53-3);Calcitonin Gene Related Peptide (rat)(96827-03-1);Calcitonin Gene Related Peptide II (human)(98824-26-1);Endothelin-1(117399-94-7);Angiotensin III (human)(100900-06-9);Angiotensin I (human)(70937-97-2);ANP (1-28); Carperitide(89213-87-6);Renin Substrate Tetradecapeptide (rat)(110200-37-8);Adrenomedullin (1-52) (human)(148498-78-6);Intermedin (human)(1188922-20-4);Angiotensin I/II (1-7)(51833-78-4);Rat Renin Inhibitor Peptide(110200-37-8);Urotensin II (goby)(9047-55-6);Urotensin II (human)(251293-28-4);Angiotensin I (human)(70937-97-2);Angiotensin II (human)(4474-91-3);Fusion Inhibitory Peptide(75539-79-6);Angiotensin I/II (1-7)(51833-78-4);Thrombin substrate();Tryptophan Motif Peptide();Thrombin Sensitive Peptide();PAR-1 Agonist peptide();thrombin receptor Atagonist(207553-92-2);PAR-2 amide (1-6)(190383-13-2);Alpha-2 Plasmin Inhibitor; Serpin Peptidase Inhibitor();Caspase-3 Inhibitor I();FITC-C6-Tyr-Val-Ala-Asp-Ala-Pro-Lys(DNP)();Caspase Inhibitor II();Calcium Like Peptide 3(261969-05-5);Caspase-8 Inhibitor I(886462-83-5);Caspase-8 Inhibitor(210344-98-2);GSK-3 beta Peptide Inhibitor();Apopain Substrate(169332-61-0);Caspase-1 Inhibitor I(201608-12-0);Angiotensin I/II (1-7)(51833-78-4);Substance P(33507-63-0);Fibronectin-Binding Protein(119977-20-7);biotin labeled Steroid Receptor Coactivator-1 (SRC-1)();MMP Inhibitor 1(124168-73-6);Cyclo (-RADfE)();Integrin Binding Peptide(278792-07-7);MG-132(133407-82-6);Fluorogenic MMP Substrate(121282-17-5);Angiotensin I/II (1-7)(51833-78-4);Kisspeptin-10, Kiss1 (fish)();Kisspeptin-10, Kiss2 (fish, frog)();Calpain Substrate();Substrate for Tyrosine Protein Kinase(81493-98-3);Melittin(20449-79-0);5-Fam-Woodtide(1566528-51-5);Pannexin-1; Panx1();CHK1 and CHK2 Substrate();Malaria Aspartyl Proteinase FRET Substrate（Dabcyl-Edans pair）(263718-22-5);Fluorogenic MMP Substrate(121282-17-5);β-Secretase Substrate I (MCA-DNP pair)();α-Secretase Substrate I（MCA-DNP pair）();Fluorogenic MMP-2 Substrate(256394-92-0);Calpain Substrate(1914987-47-5);Pam3CSK4(112208-00-1);Thymosin Alpha 1(62304-98-7);L-Selectin Peptide();Bradykinin (Human, Bovine, Rat, Mouse)(58-82-2);CCK-33 (Porcine)(67256-27-3);CNP-53 (Human)(141294-77-1);TFF1 (Human)();IL 15 (Human)();β-Defensin-1 (human)();Decorsin();Glucagon (human)(16941-32-5);IKK-4374-V(209005-05-0);Arphamenine B();Z-VAD(OMe)-FMK(187389-52-2);DABCYL-Lys-HCoV-SARS(730985-86-1);Thymosin-b4();IDE Inhibitor 6bK(1774353-12-6);Neuropeptide S(412938-67-1);Substance P(33507-63-0);Neuropeptide Y(90880-35-6);Neurotensin(55508-42-4);Pro-Cortistatin (28-47)();Neurokinin B(86933-75-7);Urocortin (human)(176591-49-4);Urocortin (rat)(171543-83-2);Pro-Cortistatin (51-81)();Urocortin II (mouse)(330648-32-3);Urocortin III (human)(357952-09-1);Urocortin III (mouse)(357952-10-4);FMRF(74012-06-9);Neuromedin U (rat)(117505-80-3);Human Histone H3();Human Histone H4();Histone H3 Peptide();IFN-gamma Antagonist(158040-83-6);Ac-RGK(Ac)-AMC(660846-97-9);Ac-Gly-Ala-Lys(Ac)-AMC(577969-56-3);Peptide Standard 1 for amino acid analysis();Xenopsin(51827-01-1);索马鲁肽杂质50(2773558-66-8);Somatostatin - Impurity F生长激素抑制素- 杂质();ACTH - Asi促肾上腺皮质激素多肽-NA;Fmoc-Ile-Aib-Ile-Aib-OHNA;Fmoc-β-Ala-Ile-Aib-OHNA;Boc-Ile-Aib-OMeNA;Boc-His(Trt)-Aib-Aib-OHNA;Boc-His-Aib-OHNA;Ac-Ile-Cit-PABC-AMCNA;Tyr-{d-Ala}-Gly-{Me-Phe}-Gly-olNA;FAM-Cys-x-GRVVVSR-CONH2NA;DOTA-tris(tBu) ester(137076-54-1);FAPI-04-8(2374782-82-6);Biotinyl-GHK(299157-54-3);Acetyl hexapeptide(616204-22-9);GLUTARYL-GLY-GLY-PHE-AMC(70996-06-4);Substance P(33507-63-0);Xenopus peptide(51827-01-1);Apelin (1-13) (human)(217082-58-1);Tirzepatide(2023788-19-2);Dusquetide(931395-42-5);9-(((S)-1-((2S,4R)-4-Hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)amino)-9-oxononanoic acid(2172819-76-8);(H-Cys-Gly-OH)2(7729-20-6);1-tert-butyl 5-methyl (2S)-2-{[(benzyloxy)carbonyl]amino}pentanedioate(57732-63-5);Tri(Amino-PEG4-amide)-amine(2523025-41-2);Semaglutide(910463-68-2);Carbetocin Acid impurity(1352167-71-5);DO3AM-acetic acid(913528-04-8);1H-1,4,7-Triazonine-1,4,7-tria-cetic acid,hexahydro-, 1,4-bis(1,1-dimethylethyl) ester(1161415-28-6);palmitoyltripeptide(147732-56-7);740Y-P(1236188-16-1);O-(N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-(tert-butoxycarbonyl)-L-lysyl)-N-(tert-butoxycarbonyl)-L-threonine(944283-38-9);H-Tyr-Ala-Gly-Phe-Met-NH2(61090-95-7);MC-Val-Cit-PAB-PNP(159857-81-5);Suc-GGFG-Acid(1599440-25-1);MC-Val-Cit-PAB-OH(159857-80-4);Fmoc-Val-Cit-PAB(159858-22-7);Fmoc-Val-Cit-PAB-PNP(863971-53-3);Val-cit-PAB-OH(159857-79-1);GGFG-Acid(1599440-20-6);DBCO-PEG4-Acid(1537170-85-6);DBCO-PEG4-NHS(1427004-19-0);p-NH2-Bn-DOTA-tetra(t-Bu ester)(446061-19-4);DOTAGA-tetra(t-Bu ester)(306776-79-4);DOTA-tris (t-Bu ester)(137076-54-1);DOTA-mono-NHS tris(t-Bu ester)(819869-77-7);Maleimido-mono-amide-DOTA-tris (t-Bu ester)(1613382-10-7);p-NO2-Bn-DOTA(116052-88-1);p-NCS-Bn-DOTA(127985-74-4);p-NH2-Bn-DOTA(181065-46-3);DOTA-NHS-ester(1823122-52-6);Maleimido-mono-amide-DOTA(1006711-90-5);DOTAM-mono-acid(913528-04-8);p-NCS-Bn-TCMC(282097-63-6);DOTAM-NHS-ester(2236057-47-7);Fmoc-Leu-Ser[PSI(Me,Me)Pro]-OH(339531-50-9);Fmoc-Lys(Boc)-Ser[PSI(Me,Me)Pro]-OH(957780-54-0);Fmoc-Tyr(tBu)-Ser[PSI(Me,Me)Pro]-OH(878797-09-2);Fmoc-Asn(Trt)-Ser[PSI(Me,Me)Pro]-OH(920519-33-1);Fmoc-GIn(Trt)-Ser[PSI(Me,Me)Pro]-OH(1821378-64-6);Fmoc-Ala-Ser[PSI(Me,Me)Pro]-OH(252554-78-2);Fmoc-Val-Ser[PSI(Me,Me)Pro]-OH(186023-49-4);Fmoc-Thr(tBu)-Ser(Psi(Me,Me)pro)-OH(1425938-63-1);Fmoc-Ile-Ser[PSI(Me,Me)Pro]-OH(1147996-34-6);Fmoc-Phe-Ser[PSI(Me,Me)Pro]-OH(878797-01-4);Fmoc-Gly-Ser[PSI(Me,Me)Pro]-OH(1095952-22-9);Fmoc-Leu-Thr[PSI(Me,Me)Pro]-OH(955048-89-2);Fmoc-Ala-Thr[PSI(Me,Me)Pro]-OH(252554-79-3);Fmoc-Gln(Trt)-Thr(Psi(Me,Me)pro)-OH(1572725-72-4);Fmoc-Asp(tBu)-Thr[PSI(Me,Me)Pro]-OH(920519-32-0);Difelikefalin Impurities();L-lactide-phenylalanine-octreotide impurity();Carbetocin impurity();Teriparatide Impurtiy();L-lactide-phenylalanine-octreotide();Lys(D-LTD)-octreotide();Lys(L-LTD)-octreotide();D-lactide-phenylalanine-octreotide();[Tyr2(3-OH)] -Desmopressin();1-L-Cys-Etelcalcetide();2-L-Ala-Etelcalcetide();6-L-Ala-Etelcalcetide();Polymyxin Impurity ();Semaglutide Impurity();Peptide customization();Contract Customization CRO();Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH(2460751-66-8);Atosiban impurity();Carbetocin Glu impurity(69228-04-2);Carbetocin {d-Asn5}(1631754-27-2);H-Gly-Pro-Hyp-OH(2239-67-0)

第二十三届世界制药原料中国展

2025-03-06至2025-07-31

W8C55

Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals;CMO & CRO;Biotech